// App-Quantinova.ai

FRI0138 : THE IMPORTANCE OF CYSTATIN C AS A PREDICTOR OF ACCELERATED ATHEROSCLEROSIS IN PREMENOPAUSAL NON-DIABETIC PATIENTS WITH RHEUMATOID PATIENTS

Researchers

Presenter

  • I. Holc

Principal Investigators

  • A. Pahor

  • R. Hojs.

Medical Centers

  • Dept. of Rheumatology, UMC Maribor, Maribor, Slovenia

Locations

  • Slovenia

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Chronic kidney disease

  • Rheumatoid arthritis

  • Coronary Artery Disease

  • Type 1 diabetes mellitus

  • Renal disease

  • Inflammatory Arthritis

  • Diabetes

Biomarkers

  • C reactive protein

  • Creatinine

  • Cystatin C

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved